Vivo Capital »

Odyssey Therapeutics shares owned by Vivo Capital

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 575k 18.71

More positions owned by Vivo Capital

Trevi Therapeutics Common (TRVI)
Praxis Precision Medicines Common (PRAX)
Erasca Common (ERAS)
Arrivent BioPharma Common (AVBP)
Abivax SA - Sponsored Ads (ABVX)
Tango Therapeutics Common (TNGX)
Corvus Pharmaceuticals Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Tenax Therapeutics Common (TENX)
Aclaris Therapeutics Common (ACRS)
Dyne Therapeutics Common (DYN)
Dianthus Therapeutics Common (DNTH)
Alto Neuroscience Common (ANRO)
DBV Technologies SA Sponsored Ads (DBVT)

View all positions for Vivo Capital

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital
EcoR1 Capital

View all funds holding Odyssey Therapeutics